Edition:
United Kingdom

Vermillion Inc (VRML.OQ)

VRML.OQ on NASDAQ Stock Exchange Capital Market

0.89USD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
$0.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
16,864
52-wk High
$2.09
52-wk Low
$0.88

Chart for

About

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's... (more)

Overall

Beta: 2.31
Market Cap(Mil.): $92.11
Shares Outstanding(Mil.): 56.16
Dividend: --
Yield (%): --

Financials

  VRML.OQ Industry Sector
P/E (TTM): -- 82.81 32.74
EPS (TTM): -0.21 -- --
ROI: -130.35 2.00 14.38
ROE: -161.84 3.49 16.08

BRIEF-Vermillion Announces Pricing Of $15 Mln Concurrent Public Offerings Of Stock

* VERMILLION, INC. ANNOUNCES PRICING OF $15 MILLION CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND PREFERRED STOCK

13 Apr 2018

BRIEF-Vermillion Reports Qtrly Loss Per Share $0.05

* VERMILLION REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

13 Mar 2018

BRIEF-Vermillion Announces Agreement With Bluecross Blueshield Of Illinois

* VERMILLION ANNOUNCES AGREEMENT WITH BLUECROSS BLUESHIELD OF ILLINOIS Source text for Eikon: Further company coverage:

18 Jan 2018

Competitors

Earnings vs. Estimates